Cargando…
MiR-429 Inhibits Oral Squamous Cell Carcinoma Growth by Targeting ZEB1
BACKGROUND: Oral squamous cell carcinoma (OSCC) is the sixth most common human malignancy worldwide. To develop new therapeutics requires elucidation of the underlying mechanism of OSCC pathogenesis. The role of miR-429 in OSCC remains unknown. MATERIAL/METHODS: The level of miR-429 and ZEB1 in OSCC...
Autores principales: | Lei, Wanke, Liu, Yun-e, Zheng, Yuzhu, Qu, AG Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324578/ https://www.ncbi.nlm.nih.gov/pubmed/25640197 http://dx.doi.org/10.12659/MSM.893412 |
Ejemplares similares
-
MiR-429 suppresses the progression and metastasis of osteosarcoma by targeting ZEB1
por: Deng, Yi, et al.
Publicado: (2017) -
LncRNA LINC01303 Promotes the Progression of Oral Squamous Cell Carcinomas via the miR-429/ZEB1/EMT Axis
por: Sun, Bo, et al.
Publicado: (2021) -
Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015) -
LINC00894 Enhances the Progression of Breast Cancer by Sponging miR-429 to Regulate ZEB1 Expression
por: Meng, De-feng, et al.
Publicado: (2021) -
MAPKAPK5-AS1 drives the progression of hepatocellular carcinoma via regulating miR-429/ZEB1 axis
por: Peng, Zongqing, et al.
Publicado: (2022)